The Serum Galactomannan Index Predicts Mortality in Hematopoietic Stem Cell Transplant Recipients With Invasive Aspergillosis | Zendy

Cynthia E. Fisher | Zendy; Anne M. Stevens | Zendy; Wendy M. Leisenring | Zendy; Steven A. Pergam | Zendy; Michael Boeckh | Zendy; Tobias M. Hohl | Zendy

Open Access

The Serum Galactomannan Index Predicts Mortality in Hematopoietic Stem Cell Transplant Recipients With Invasive Aspergillosis

Author(s) -

Cynthia E. Fisher,

Anne M. Stevens,

Wendy M. Leisenring,

Steven A. Pergam,

Michael Boeckh,

Tobias M. Hohl

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cit393

Subject(s) - galactomannan , medicine , aspergillosis , bronchoalveolar lavage , hematopoietic stem cell transplantation , immunology , haematopoiesis , hematopoietic cell , gastroenterology , transplantation , lung , stem cell , genetics , biology

We examined the relationship between serum and bronchoalveolar lavage (BAL) galactomannan index (GMI) values and mortality in allogeneic hematopoietic cell transplant recipients with invasive pulmonary aspergillosis. Using a clinical sign and symptom-initiated approach, we found that the serum but not the BAL GMI level correlated with 42- and 180-day patient mortality.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research